Logo

American Heart Association

  2
  0


Final ID: MDP456

Accelerometer-Measured Sedentary Behavior and Future Cardiovascular Disease

Abstract Body (Do not enter title and authors here): Background: Current consensus guidelines emphasize the importance of achieving 150 minutes or more of moderate to vigorous physical activity (MVPA) per week to promote cardiovascular health but give little guidance about sedentary behavior.
Research Question: Is sedentary behavior associated with cardiovascular (CV) disease in a manner distinct from insufficient physical activity?
Aims: Examine associations between accelerometer-measured sedentary behavior with risk of specific CV outcomes, including potential interactions with MVPA.
Methods: Using 89,530 individuals providing one week of accelerometer-based physical activity data from the UK Biobank, we fit Cox models adjusted for demographic and lifestyle factors to assess associations between sedentary time (as a spline term) and incident atrial fibrillation (AF), myocardial infarction (MI), heart failure (HF), and CV mortality. We assessed the potential effect of MVPA on these associations by including MVPA as an adjustment variable, as well as performing subgroup analyses stratified at the guideline-recommended MVPA threshold.
Results: Among 89,530 individuals (age 62±8 years, 56.4% women) undergoing accelerometry, median sedentary time was 9.4 hours/day (quartile-1: 8.2, quartile-3: 10.6). In multivariable models, using the second quartile (8.2-9.4 hours/day) as a referent, sedentary time in the top quartile (>10.6 hours/day) was associated with greater risk of HF (hazard ratio [HR] 1.45, 95% CI 1.28-1.65), and CV mortality (HR 1.62, 95% CI 1.34-1.96), with evidence of a threshold effect at 10.6 hours/day. Higher sedentary time was also associated with greater risk of incident AF (HR 1.11, 95% CI 1.01-1.21) and MI (HR 1.15, 95% CI 1.00-1.32), with an approximately linear relation. Associations with HF and CV mortality persisted after adjustment for MVPA, as well as among individuals both above and below the guideline-based activity threshold of ≥150 minutes MVPA/week.
Conclusions and Relevance: Sedentary behavior is broadly associated with future adverse CV outcomes. For HF and CV mortality, associations appear distinct from insufficient MVPA, and sedentary time in excess of 10.6 hours/day conferred an increased risk.
  • Ajufo, Ezimamaka  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Kany, Shinwan  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Ramo, Joel  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Churchill, Timothy  ( MASSACHUSETTS GENERAL HOSPITAL , Boston , Massachusetts , United States )
  • Guseh, James  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Aragam, Krishna  ( MASSACHUSETTS GENERAL HOSPITAL , Boston , Massachusetts , United States )
  • Ellinor, Patrick  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Khurshid, Shaan  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Ezimamaka Ajufo: DO NOT have relevant financial relationships | Shinwan Kany: DO NOT have relevant financial relationships | Joel Ramo: DO NOT have relevant financial relationships | Timothy Churchill: DO NOT have relevant financial relationships | James Guseh: No Answer | Krishna Aragam: No Answer | Patrick Ellinor: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bayer AG:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Bayer AG:Active (exists now) | Shaan Khurshid: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Lifestyle Behaviors and Cardiovascular Disease: Impact, Interventions, and Insights

Saturday, 11/16/2024 , 09:30AM - 10:45AM

Moderated Digital Poster Session

More abstracts on this topic:
A randomized controlled trial of antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherosclerosis: The ATIS-NVAF trial

Okazaki Shuhei, Uchida Kazutaka, Asakura Koko, Omae Katsuhiro, Yamamoto Haruko, Hirano Teruyuki, Toyoda Kazunori, Iguchi Yasuyuki, Noguchi Teruo, Okada Yasushi, Kitagawa Kazuo, Tanaka Kanta, Sakai Nobuyuki, Yamagami Hiroshi, Yazawa Yukako, Doijiri Ryosuke, Koga Masatoshi, Ihara Masafumi, Yamamoto Shiro, Kamiyama Kenji, Honda Yuko

A RETROSPECTIVE EVALUATION OF RESOURCE UTILIZATION AND OUTCOMES IN PATIENTS USING MOBILE ECG DEVICES FOLLOWING ABLATION FOR ATRIAL FIBRILLATION

Fairman Alix, Loh Alexander, Druml Lauren, Triplett Cynthia, Liu Taylor, Pursnani Seema

More abstracts from these authors:
A Deep Learning Digital Biomarker for Mitral Valve Prolapse using Echocardiogram Videos

Al-alusi Mostafa, Khurshid Shaan, Sanborn Danita, Picard Michael, Ho Jennifer, Maddah Mahnaz, Ellinor Patrick, Lau Emily, Small Aeron, Reeder Christopher, Shnitzer Dery Tal, Andrews Carl, Kany Shinwan, Ramo Joel, Haimovich Julian

Prediction of Incident Atrial Fibrillation Using Handheld Single-Lead Electrocardiograms from the VITAL-AF Trial

Khurshid Shaan, Atlas Steven, Maddah Mahnaz, Singer Daniel, Ellinor Patrick, Friedman Sam, Al-alusi Mostafa, Kany Shinwan, Anderson Christopher, Ho Jennifer, Mcmanus David, Ashburner Jeffrey, Lubitz Steven

You have to be authorized to contact abstract author. Please, Login
Not Available